Sodium Lactate Negatively Regulates Shewanella putrefaciens CN32 Biofilm Formation via a Three-Component Regulatory System (LrbS-LrbA-LrbR)

Applied and Environmental Microbiology
Cong LiuWeijie Liu

Abstract

The capability of biofilm formation has a major impact on the industrial and biotechnological applications of Shewanella putrefaciens CN32. However, the detailed regulatory mechanisms underlying biofilm formation in this strain remain largely unknown. In the present report, we describe a three-component regulatory system which negatively regulates the biofilm formation of S. putrefaciens CN32. This system consists of a histidine kinase LrbS (Sputcn32_0303) and two cognate response regulators, including a transcription factor, LrbA (Sputcn32_0304), and a phosphodiesterase, LrbR (Sputcn32_0305). LrbS responds to the signal of the carbon source sodium lactate and subsequently activates LrbA. The activated LrbA then promotes the expression of lrbR, the gene for the other response regulator. The bis-(3'-5')-cyclic dimeric GMP (c-di-GMP) phosphodiesterase LrbR, containing an EAL domain, decreases the concentration of intracellular c-di-GMP, thereby negatively regulating biofilm formation. In summary, the carbon source sodium lactate acts as a signal molecule that regulates biofilm formation via a three-component regulatory system (LrbS-LrbA-LrbR) in S. putrefaciens CN32.IMPORTANCE Biofilm formation is a significant capability used by...Continue Reading

References

Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·D H Figurski, D R Helinski
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·G KarimovaD Ladant
Mar 13, 2002·Archives of Microbiology·Sibylle Kaspar, Michael Bott
May 8, 2003·Journal of Clinical Microbiology·Leonardo PaganiPeter Mian
Jun 7, 2003·Molecular Microbiology·Mikkel KlausenTim Tolker-Nielsen
Mar 26, 2004·Nature Reviews. Microbiology·Luanne Hall-StoodleyPaul Stoodley
May 15, 2004·Environmental Microbiology·Michael Y Galperin
Jun 10, 2004·Environmental Microbiology·Lotte LambertsenSøren Molin
Nov 18, 2004·Journal of Bacteriology·Kai M ThormannAlfred M Spormann
Jan 22, 2005·Molecular Microbiology·Hemantha D KulasekaraStephen Lory
May 11, 2005·Molecular Microbiology·Jeffrey A GralnickDianne K Newman
Aug 27, 2005·Nature·Lucas R HoffmanSamuel I Miller
Mar 21, 2006·Journal of Bacteriology·Kai M ThormannAlfred M Spormann
Jul 4, 2006·Journal of Bacteriology·Yih-Ling TzengDavid S Stephens
Jan 16, 2008·Antimicrobial Agents and Chemotherapy·Jaeeun KimJeyong Yoon
May 8, 2008·Applied Microbiology and Biotechnology·Azeem KhalidDavid E Crowley
Mar 17, 2009·Nature Reviews. Microbiology·Regine Hengge
Sep 17, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R CamilliL Baldassarri
Aug 23, 2011·Journal of Molecular Biology·Orr AshenbergAmy E Keating
Jan 10, 2012·Current Opinion in Microbiology·Holger SondermannFitnat H Yildiz
Jul 4, 2012·Annual Review of Microbiology·Emily J Capra, Michael T Laub
Mar 9, 2013·Microbiology and Molecular Biology Reviews : MMBR·Ute RömlingMark Gomelsky
Sep 26, 2013·Proceedings of the National Academy of Sciences of the United States of America·Kirsten R GuckesMaria Hadjifrangiskou
Mar 25, 2014·Dose-response : a Publication of International Hormesis Society·Mandy NgJeffrey B Kaplan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Bacterial Protein Structures (ASM)

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.